TABLE 1.
Baseline characteristics of 115 patients with an acute PCI-treated STEMI
| Patients | |
|---|---|
| Age (years) | 59 (52, 68) |
| Male, n (%) | 97 (84) |
| Previous disorder: | |
| MI, n (%) | 5 (4.3) |
| Angina pectoris, n (%) | 3 (2.6) |
| Hypertension (treated), n (%) | 23 (20.0) |
| Hyperlipidemia (treated), n (%) | 9 (7.8) |
| Status at baseline: | |
| Current smoker, n (%) | 49 (42.6) |
| cTnTmax (μg/L) | 5.0 (2.5, 9.7) |
| BMI (kg/m2) | 26 (24.3, 28.6) |
| Waist circumference (cm) | 99 (94, 106) |
| Stent in culprit lesion, n (%) | 109 (94.8) |
| Gp IIb/IIIa inhibitor-treated, n (%) | 39 (33.9) |
| Single-coronary vessel disease, n (%) | 73 (63.5) |
| Double-coronary vessel disease, n (%) | 34 (29.6) |
| Triple-coronary vessel disease, n (%) | 8 (7.0) |
| Time from symptoms to balloon (min) | 239 (155, 370) |
| Medication at admission: | |
| Aspirin | 10 (8.7) |
| β-Blockers | 11 (9.6) |
| Lipid-lowering agents | 7 (6.1) |
| ACE inhibitors | 3 (2.6) |
| Angiotensin II receptor blockers | 11 (9.6) |
Data are presented as median values (25th, 75th percentiles) or proportions (%). cTnTmax, cTnT maximum; Gp, glycoprotein.